This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here. Hide this message

About us

Our key areas of work

Consistency of care

Clinical leaders continually review our systems of work to ensure that patients in our care receive a consistent quality of service 24 hours a day, seven days a week.

Reviews of learning from deaths, incidents, complaints and litigation indicates that in some instances patients can wait too long to be seen or have treatment initiated. This can be a significant and contributing factor in the failure to promptly identify and treat some patients.

We will ensure that:

  • Patients who are admitted to hospital for urgent treatment are assessed promptly
  • Every patient who requires to be seen daily by a doctor, is seen daily
  • All patients have a consultant review within 14 hours of being admitted to hospital
  • Patients get access to specialist, consultant-directed interventions
  • Patients get access to diagnostic tests within a 24-hour turnaround time or within 12 hours for urgent cases and within one hour for critical patients

Early detection and treatment

Problems surrounding the management of the deteriorating patient are often multifactorial.

To improve the medical response, we have developed a deteriorating patient pathway to support the junior doctors in their initial assessment. Targeted work on the recognition and treatment of Sepsis will continue.

The escalation policy is a graded response which ensures a structured and timely

approach to the deteriorating patient. The Trust will see implementation of NEWS2 in spring 2019 which will provide an opportunity to review our escalation policy.

We need to strengthen the recording of patients' ceiling of care as a fundamental part of this. Further work is also planned to help identify barriers and challenges.

We will:

  • Increase knowledge of critical illness recognition and management
  • Have a clear process for early detection of the deteriorating patient
  • Establish robust escalation processes uniformly throughout the Trust
  • Promote robust risk assessment and intervention for patients at risk of harm
  • Provide prompt initiation of treatment for those where time to treatment is essential
  • Ensure robust communication between disciplines when making escalation decisions.

Right care, in the right place, at the right time

Ensuring our patients are in the right place to receive the right care, optimising flow and tackling unnecessary prolonged stays in hospital are all key goals for reducing harm. Improving the movement of patients between departments is recognised to reduce delays and bottlenecks in clinical areas. Currently when our Emergency Departments are busy there is often a delay in getting an ill patient to an inpatient ward. Similarly when the hospital is busy the Operating Department can experience delays waiting to transfer patients to Critical Care.

The key to improving patient flow in hospitals is believed to be reducing unwarranted variation in process. A key part to ensuring our patients are in the right place to receive the right care, improving flow and reducing delays is the SAFER care bundle. Simply, it relies on implementation of a bundle of elements of best practice to achieve the cumulative benefits.

We will implement the SAFER Patient Flow Bundle:

  • Senior Review; all patients should have a senior review before midday by a clinician able to make management and discharge decisions
  • All patients will have an Expected Discharge Date and Clinical Criteria for Discharge set by assuming ideal recovery and assuming no unnecessary waiting
  • Flow of patients to commence at the earliest opportunity from assessment units to inpatient wards. Wards routinely receiving patients from assessment units will ensure the rst patient arrives on the ward by 10am
  • Early discharge; 33% of patients will be discharged from base inpatient wards before midday
  • Review; a systematic multi-disciplinary team (MDT) review of patients with extended lengths of stay > 7 days, to get them 'home first'.

Infection prevention and control

Hospital acquired infection remains a threat to the well- being of our patients and antimicrobial resistance presents additional challenges in care.

The emergence of antimicrobial resistance, for example Carbapenamase-producing Enterobacteriaceae (CRE/CPE) is a key concern and we will continually review our antimicrobial formulary and audit compliance with antimicrobial prevention guidelines including documentation of indication and course length.

The Director of Infection Prevention and Control will continue to monitor and report to the Trust Board of Directors, data on IPC compliance, and continue to promote a culture amongst all staff of infection prevention awareness.

We will reduce the Incidence of Healthcare Associated Infections and encourage Antimicrobial Stewardship by:

  • Ensuring awareness of IPC measures via staff education, particularly hand hygiene and aseptic non touch technique
  • Continuing to report surveillance and audit results to Executive Board and Board of Directors and to improve the results where necessary
  • Improving the quality of antimicrobial prescribing and promote antimicrobial stewardship and commitment to improve
  • Screening patients for resistant infections and provide timely isolation
  • Learning from adverse events and ensuring MDT involvement in Post Infection Review (PIR) processes.

Areas of frequent harm

Analysis of adverse events in the Trust identities recurrent themes of potentially avoidable harm. These include morbidity and mortality from falls, errors  associated with medicine administration and prescribing, development and deterioration of pressure ulcers and Never Events. Each will be subject to Serious Incident investigation and progress will be reported to Trust Board of Directors.

The National Confidential Enquiry into Patient Outcome and Death (NCEPOD) has identified a number of recurrent themes and common conditions for which the Trust will monitor as part of the Serious Incident review process, to ensure areas of frequent harm are addressed.

We will:

  • Continue to reduce the incidence of serious harm to patients who fall in our care
  • Monitor and respond to trends relating to medicine prescribing and administration following the implementation of Electronic Prescribing and Medicines Administration (EPMA)
  • Continue to reduce the incidence of pressure ulcer development to patients in our care
  • Introduce local safety standards for invasive procedures.
  • Learn from 'near misses'
  • Develop capability and capacity to carry out good quality investigations
  • Reduce harm caused by hospital related functional decline (deconditioning) as a result of unnecessary prolonged hospital stays.

Learning from death

Learning all we can from critically examining care that patients receive before they die can teach us how to deliver safer care. This element of the strategy will continue to refine systems which ensure that a standardised approach will be taken to performing mortality reviews. Where trends can be identified, learning from reviews will be cascaded efficiently and improvements to patient safety made.

We are refining systems for mortality review which will be consistently applied in all clinical areas including our community hospitals. Where we are concerned about care prior to death we will investigate using either our serious incident process or the recently introduced structured judgement casenote review.

We will:

  • Continue to promote and develop the existing processes of mortality review for all patients who die in our hospitals
  • Develop processes for dissemination of learning from mortality review
  • Ensure that all in-patient deaths are promptly reviewed by a consultant
  • Promote discussion of learning from mortality review at department governance meetings using the three monthly summary reports.
IMG_3571

Fundraising

DSC_5694

A-Z of Services

Chinese Poland

View all languages >